Spinal zap trial offers hope for rare stiffness disease
NCT ID NCT06242678
First seen Jun 27, 2026 · Last updated Sep 01, 2026 · Updated 2 times
Summary
This small pilot study tested whether spinal cord stimulation could reduce painful muscle rigidity and spasms in people with stiff person syndrome, a rare autoimmune condition. Two adults with the disease received temporary stimulation for up to 10 days, and researchers measured changes in pain, spasm frequency, sleep, and mood. The goal was to gather early safety and effectiveness data to guide future research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
2 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Is 18 years of age or older at the time that the Informed Consent Form (ICF) is signed. * Has been clinically diagnosed with stiff person syndrome * Has clinical symptoms of muscle rigidity and spasms in the truncal (including abdominal, thoracic paraspinal, and pectoral) or proximal lower limb musculature * Has Cerebrospinal fluid (CSF) Anti-glutamic acid decarboxylase 65 (anti-GAD65) antibodies or serum anti-GAD65 antibodies present at any titer * Is currently trying or has tried in the past at least two conventional therapies with insufficient symptomatic relief or intolerable side effects (such as nonsteroidal anti- inflammatory drugs, topical patches/creams/gels/ointments, physical therapy, acupuncture, bracing, assistive devices, and lifestyle modification). * If taking oral medications, is willing to maintain a stable regimen for the duration of the study period. * Is cleared for an implantable medical device by licensed mental health provider. * Is an appropriate candidate for the surgical procedures required in this study based on clinical judgement of the study physician. * Is willing to and capable of giving written informed consent. * Is willing and able to comply with study-related requirements and procedures and attend scheduled visits. Exclusion criteria: * Is less than 18 years of age at the time at the time that the Informed Consent Form (ICF) is signed. * Has a Body Mass Index (BMI) \> 45. * Has a history of spine surgery or is planning to receive a spinal injection or procedure while participating in the study, unless this procedure can be postponed until after study completion. * Has radiological findings or evidence of moderate to severe central spinal canal stenosis or neuroforaminal stenosis at any thoracic level or laterality. * Has radiological findings or evidence of moderate/severe central spinal canal stenosis at any cervical or lumbar level. * Has had an epidural steroid injection within 6 weeks of enrollment. * Has a history of infection of the spine within 6 months of enrollment. * Has received intravenous immunoglobulin therapy within 30 days or is unwilling to maintain a stable regimen (no change in dosage or frequency) during the study period. * Has a history of opioid misuse or current chronic opioid therapy. * Has evidence of a coagulation abnormality or low platelet count (\<120,000) indicated on Complete Blood Count test at screening, or has a history of abnormal bleeding, or if unable to pause anticoagulation therapy in accordance with accepted guidelines for a spinal cord stimulator trial. * Has a current local infection at the anticipated surgical entry site, active systemic infection, or active malignancy. * Has a medical condition or pain in other area(s) not intended to be treated in this study, that could interfere with study procedures, accurate pain reporting, and/or confound evaluation of study endpoints, as determined by the Investigator (such as radicular pain, post-herpetic neuralgia, central canal stenosis of the cervical, thoracic or lumbar spine, critical limb ischemia due to peripheral vascular disease, or small vessel disease). * Has a history of untreated major depressive disorder, or history of any mental health disorder with psychotic features, such as schizophrenia. * Is pregnant (confirmed via pregnancy test) or plans on becoming pregnant during the study period. * Has had, within six months of enrollment, a significant untreated addiction to dependency producing medications, alcohol or illicit drugs. * Is concomitantly participating in another interventional clinical trial. * Is involved in an injury claim for a study-related chronic pain that is under current litigation. * Is a recipient of temporary Social Security Disability Insurance (SSDI) benefits due to study related chronic pain. * Has a pending or approved worker's compensation claim for study-related chronic pain. * Has low English language literacy interfering with the ability to complete study requirements.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Stiff person syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, 27157, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can CRISPR-Edited cells stop autoimmune attacks on the brain?
- Can a simple blood test unlock the secrets of brain autoimmune diseases?
- New hope for stiff person syndrome: drug trial aims to ease muscle stiffness and improve walking
- Engineered immune cells take on lupus and scleroderma in early trial
- Could a stem cell transplant stop the immune system from attacking the brain?
- CAR T-Cell therapy: what happens years later?